INTRAVITREAL PHARMACOKINETICS OF 5-FLUOROURACIL (5-FU) IN NORMAL AND SURGICALLY TRAUMATIZED RABBIT EYES

被引：0
|
作者：
LOPEZ, MI [1 ]
PASTOR, JC [1 ]
MATEU, CJ [1 ]
ALONSO, JI [1 ]
NOZAL, MJ [1 ]
PAMPLIEGA, A [1 ]
机构：
[1] UNIV VALLADOLID,INST OFTALMOBIOL APLICADA,VALLADOLID,SPAIN
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1993年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1423 / 1423
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF INTRAVITREAL 5-FLUOROURACIL (5-FU) IN THE RABBIT
    LOPEZ, MI
    MATE, A
    MATEU, C
    ALONSO, JI
    PAMPLIEGA, A
    DELNOZAL, MJ
    PASTOR, JC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 727 - 727
  • [2] Modulation of plasma pharmacokinetics of 5-fluorouracil (5-FU) by eniluracil
    Abaogye, EO
    Saleem, A
    Osman, S
    Yap, J
    Harte, RJA
    Purnell, C
    O'Callaghan, M
    Lucas, VS
    Jones, T
    Price, PM
    BRITISH JOURNAL OF CANCER, 1999, 80 : 95 - 95
  • [3] 5-FLUOROURACIL (5-FU) PHARMACOKINETICS FOLLOWING VARIOUS ROUTES OF ADMINISTRATION
    SADEE, W
    FINN, C
    SCHWANDT, HJ
    YALE, L
    LEE, YT
    BATEMAN, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 187 - 187
  • [4] A PERFUSED RABBIT EYE AS A MODEL FOR INVIVO INTRAOCULAR PHARMACOKINETIC STUDIES - CLEARANCE OF INTRAVITREAL 5-FLUOROURACIL (5-FU)
    LOPEZ, I
    PASTOR, JC
    ALONSO, JI
    MATE, A
    MATEU, C
    DELNOZAL, MJ
    PAMPLIEGA, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 1296 - 1296
  • [5] 5-FLUOROURACIL (5-FU) PRESENTING AS A STEMI
    Okor, Ivana
    Ghosh, Priyanka
    Bhattarai, Shraddha
    Sattur, Sudhakar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3439 - 3439
  • [6] Photosensitivity due to 5-fluorouracil (5-FU)
    von Moos, R
    Sauter, C
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 129 (1-2) : 52 - 52
  • [7] ALTERED PHARMACOKINETICS OF HIGH-DOSE 5-FLUOROURACIL (5-FU) WITH ALLOPURINOL (HPP) AND ANALYSIS OF ROUTES OF 5-FU ACTIVATION
    SCHWARTZ, PM
    HYDE, CM
    TUREK, PJ
    CADMAN, E
    HANDSCHUMACHER, RE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 222 - 222
  • [8] Oxaliplatin (L-OHP) does not influence the pharmacokinetics of 5-fluorouracil (5-FU)
    Joel, SP
    Richards, F
    Halstead, F
    Seymour, M
    BRITISH JOURNAL OF CANCER, 2000, 83 : 68 - 68
  • [9] UFT:　biochemical modulation for 5-fluorouracil (5-FU)
    田口铁男
    中华医学杂志(英文版), 1997, (04) : 55 - 57
  • [10] UFT: Biochemical modulation for 5-fluorouracil (5-FU)
    Taguchi, T
    CHINESE MEDICAL JOURNAL, 1997, 110 (04) : 294 - 296
12345